CCR1-mediated STAT3 tyrosine phosphorylation and CXCL8 expression in THP-1 macrophage-like cells involve pertussis toxin-insensitive Gα 14/16 signaling and IL-6 release

Journal of Immunology

Volumn 189, Issue 11, 2012, Pages 5266-5276

  Lee, Maggie M K ^a   Chui, Ricky K S ^a   Tam, Issan Y S ^b   Lau, Alaster H Y ^b   Wong, Yung H ^a  

^a HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

^b Chinese University of Hong Kong   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CCL15 CHEMOKINE; CHEMOKINE; CHEMOKINE RECEPTOR CCR1; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; INTERLEUKIN 6; INTERLEUKIN 8; SERINE; STAT3 PROTEIN; TYROSINE; UNCLASSIFIED DRUG;

ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOSOL; EMBRYO; ERYTHROLEUKEMIA CELL; HUMAN; HUMAN CELL; MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION;

ANTIBODIES; CELL NUCLEUS; CHEMOKINES, CC; CYTOSOL; GENE EXPRESSION; GTP-BINDING PROTEIN ALPHA SUBUNITS, GQ-G11; HEK293 CELLS; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; K562 CELLS; MACROPHAGE INFLAMMATORY PROTEINS; MACROPHAGES; PERTUSSIS TOXIN; PHOSPHORYLATION; PLASMIDS; PROTEIN ISOFORMS; RECEPTORS, CCR1; SERINE; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TRANSFECTION; TYROSINE;

EID: 84869840177     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1103359     Document Type: Article

References (67)

1. Allen, S. J., S. E. Crown, and T. M. Handel. 2007. Chemokine: receptor structure, interactions, and antagonism. Annu. Rev. Immunol. 25: 787-820. (Pubitemid 46697924)
2. Neote, K., D. DiGregorio, J. Y. Mak, R. Horuk, and T. J. Schall. 1993. Molecular cloning, functional expression, and signaling characteristics of a C-C chemokine receptor. Cell 72: 415-425. (Pubitemid 23059411)
3. Youn, B. S., S. M. Zhang, E. K. Lee, D. H. Park, H. E. Broxmeyer, P. M. Murphy, M. Locati, J. E. Pease, K. K. Kim, K. Antol, and B. S. Kwon. 1997. Molecular cloning of leukotactin-1: a novel human β-chemokine, a chemoattractant for neutrophils, monocytes, and lymphocytes, and a potent agonist at CC chemokine receptors 1 and 3. J. Immunol. 159: 5201-5205. (Pubitemid 127470044)
4. Gao, J. L., T. A. Wynn, Y. Chang, E. J. Lee, H. E. Broxmeyer, S. Cooper, H. L. Tiffany, H. Westphal, J. Kwon-Chung, and P. M. Murphy. 1997. Impaired host defense, hematopoiesis, granulomatous inflammation and type 1-type 2 cytokine balance in mice lacking CC chemokine receptor 1. J. Exp. Med. 185: 1959-1968. (Pubitemid 27247082)
5. Hwang, J., C. W. Kim, K. N. Son, K. Y. Han, K. H. Lee, H. K. Kleinman, J. Ko, D. S. Na, B. S. Kwon, Y. S. Gho, and J. Kim. 2004. Angiogenic activity of human CC chemokine CCL15 in vitro and in vivo. FEBS Lett. 570: 47-51. (Pubitemid 38900954)
6. Miyazaki, D., T. Nakamura, M. Toda, K. W. Cheung-Chau, R. M. Richardson, and S. J. Ono. 2005. Macrophage inflammatory protein-1α as a costimulatory signal for mast cell-mediated immediate hypersensitivity reactions. J. Clin. Invest. 115: 434-442. (Pubitemid 40385485)
7. Potteaux, S., C. Combadière, B. Esposito, S. Casanova, R. Merval, P. Ardouin, J. L. Gao, P. M. Murphy, A. Tedgui, and Z. Mallat. 2005. Chemokine receptor CCR1 disruption in bone marrow cells enhances atherosclerotic lesion development and inflammation in mice. Mol. Med. 11: 16-20.
8. Yu, R., C. S. Kim, T. Kawada, T. W. Kwon, T. H. Lim, Y. W. Kim, and B. S. Kwon. 2004. Involvement of leukotactin-1, a novel CC chemokine, in human atherosclerosis. Atherosclerosis 174: 35-42. (Pubitemid 38595437)
9. Gao, J. L., D. B. Kuhns, H. L. Tiffany, D. McDermott, X. Li, U. Francke, and P. M. Murphy. 1993. Structure and functional expression of the human macrophage inflammatory protein 1 α/RANTES receptor. J. Exp. Med. 177: 1421-1427. (Pubitemid 23117132)
10. Salcedo, R., H. A. Young, M. L. Ponce, J. M. Ward, H. K. Kleinman, W. J. Murphy, and J. J. Oppenheim. 2001. Eotaxin (CCL11) induces in vivo angiogenic responses by human CCR3+ endothelial cells. J. Immunol. 166: 7571-7578. (Pubitemid 32525638)
11. Takeda, K., T. Kaisho, N. Yoshida, J. Takeda, T. Kishimoto, and S. Akira. 1998. Stat3 activation is responsible for IL-6-dependent T cell proliferation through preventing apoptosis: generation and characterization of T cell-specific Stat3-deficient mice. J. Immunol. 161: 4652-4660. (Pubitemid 28492039)
12. 816) mutant c-Kit-mediated cytokine-independent survival and proliferation in human leukemia cells. Blood 97: 3559-3567.
13. Valdembri, D., G. Serini, A. Vacca, D. Ribatti, and F. Bussolino. 2002. In vivo activation of JAK2/STAT-3 pathway during angiogenesis induced by GM-CSF. FASEB J. 16: 225-227.
14. Takeda, K., K. Noguchi, W. Shi, T. Tanaka, M. Matsumoto, N. Yoshida, T. Kishimoto, and S. Akira. 1997. Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proc. Natl. Acad. Sci. USA 94: 3801-3804. (Pubitemid 27180453)
15. Takeda, K., B. E. Clausen, T. Kaisho, T. Tsujimura, N. Terada, I. Förster, and S. Akira. 1999. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity 10: 39-49. (Pubitemid 29077382)
16. Welte, T., S. S. Zhang, T. Wang, Z. Zhang, D. G. Hesslein, Z. Yin, A. Kano, Y. Iwamoto, E. Li, J. E. Craft, et al. 2003. STAT3 deletion during hematopoiesis causes Crohn's disease-like pathogenesis and lethality: a critical role of STAT3 in innate immunity. Proc. Natl. Acad. Sci. USA 100: 1879-1884. (Pubitemid 36254542)
17. Yang, J., X. Liao, M. K. Agarwal, L. Barnes, P. E. Auron, and G. R. Stark. 2007. Unphosphorylated STAT3 accumulates in response to IL-6 and activates transcription by binding to NFkappaB. Genes Dev. 21: 1396-1408. (Pubitemid 46871042)
18. Wong, M., and E. N. Fish. 1998. RANTES and MIP-1a activate stats in T cells. J. Biol. Chem. 273: 309-314. (Pubitemid 28042210)
19. Lo, R. K., and Y. H. Wong. 2006. Transcriptional activation of c-Fos by constitutively active Galpha(16)QL through a STAT1-dependent pathway. Cell. Signal. 18: 2143-2153. (Pubitemid 44636155)
20. Lo, R. K., and Y. H. Wong. 2004. Signal transducer and activator of transcription 3 activation by the δ-opioid receptor via Galpha14 involves multiple intermediates. Mol. Pharmacol. 65: 1427-1439. (Pubitemid 38668301)
21. Lo, R. K., H. Cheung, and Y. H. Wong. 2003. Constitutively active Galpha16 stimulates STAT3 via a c-Src/JAK- and ERK-dependent mechanism. J. Biol. Chem. 278: 52154-52165. (Pubitemid 38035802)
22. Amatruda, T. T., III, D. A. Steele, V. Z. Slepak, and M. I. Simon. 1991. G alpha 16, a G protein αλπηα subunit specifically expressed in hematopoietic cells. Proc. Natl. Acad. Sci. USA 88: 5587-5591.
23. Lee, M. M., and Y. H. Wong. 2009. CCR1-mediated activation of Nuclear Factor-kappaB in THP-1 monocytic cells involves Pertussis Toxin-insensitive Galpha(14) and Galpha(16) signaling cascades. J. Leukoc. Biol. 86: 1319-1329.
24. Su, Y., M. K. Ho, and Y. H. Wong. 2009. A hematopoietic perspective on the promiscuity and specificity of Galpha16 signaling. Neurosignals 17: 71-81.
25. Tian, Y. J., M. M. Lee, L. Y. Yung, R. A. Allen, P. M. Slocombe, B. M. Twomey, and Y. H. Wong. 2008. Differential involvement of Galpha16 in CC chemokine-induced stimulation of phospholipase Cbeta, ERK, and chemotaxis. Cell. Signal. 20: 1179-1189.
26. Tian, Y., D. C. New, L. Y. Yung, R. A. Allen, P. M. Slocombe, B. M. Twomey, M. M. Lee, and Y. H. Wong. 2004. Differential chemokine activation of CC chemokine receptor 1-regulated pathways: ligand selective activation of Galpha 14-coupled pathways. Eur. J. Immunol. 34: 785-795. (Pubitemid 39255926)
27. Kwon, S. H., S. A. Ju, J. H. Kang, C. S. Kim, H. M. Yoo, and R. Yu. 2008. Chemokine Lkn-1/CCL15 enhances matrix metalloproteinase-9 release from human macrophages and macrophage-derived foam cells. Nutr. Res. Pract. 2: 134-137.
28. Wang, L., J. Luo, and S. He. 2007. Induction of MMP-9 release from human dermal fibroblasts by thrombin: involvement of JAK/STAT3 signaling pathway in MMP-9 release. BMC Cell Biol. 8: 14.
29. Oba, Y., J. W. Lee, L. A. Ehrlich, H. Y. Chung, D. F. Jelinek, N. S. Callander, R. Horuk, S. J. Choi, and G. D. Roodman. 2005. MIP-1a utilizes both CCR1 and CCR5 to induce osteoclast formation and increase adhesion of myeloma cells to marrow stromal cells. Exp. Hematol. 33: 272-278. (Pubitemid 40261308)
30. Nanki, T., K. Nagasaka, K. Hayashida, Y. Saita, and N. Miyasaka. 2001. Chemokines regulate IL-6 and IL-8 production by fibroblast-like synoviocytes from patients with rheumatoid arthritis. J. Immunol. 167: 5381-5385. (Pubitemid 33009778)
31. Klezovitch, O., C. Edelstein, and A. M. Scanu. 2001. Stimulation of interleukin-8 production in human THP-1 macrophages by apolipoprotein(a). Evidence for a critical involvement of elements in its C-terminal domain. J. Biol. Chem. 276: 46864-46869.
32. Kang, S. S., S. S. Woo, J. Im, J. S. Yang, C. H. Yun, H. R. Ju, C. G. Son, E. Y. Moon, and S. H. Han. 2007. Human placenta promotes IL-8 expression through activation of JNK/SAPK and transcription factors NF-kappaB and AP-1 in PMA-differentiated THP-1 cells. Int. Immunopharmacol. 7: 1488-1495. (Pubitemid 47307434)
33. Luca, M., S. Huang, J. E. Gershenwald, R. K. Singh, R. Reich, and M. Bar-Eli. 1997. Expression of interleukin-8 by human melanoma cells up-regulates MMP-2 activity and increases tumor growth and metastasis. Am. J. Pathol. 151: 1105-1113. (Pubitemid 27424320)
34. Zhong, Z., Z. Wen, and J. E. Darnell, Jr. 1994. Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science 264: 95-98. (Pubitemid 24144493)
35. Yeh, M., N. M. Gharavi, J. Choi, X. Hsieh, E. Reed, K. P. Mouillesseaux, A. L. Cole, S. T. Reddy, and J. A. Berliner. 2004. Oxidized phospholipids increase interleukin 8 (IL-8) synthesis by activation of the c-src/signal transducers and activators of transcription (STAT)3 pathway. J. Biol. Chem. 279: 30175-30181. (Pubitemid 38937941)
36. Lau, W. W., J. K. Ng, M. M. Lee, A. S. Chan, and Y. H.Wong. 2012. Interleukin-6 autocrine signaling mediates melatonin MT(1/2) receptor-induced STAT3 Tyr (705) phosphorylation. J. Pineal Res. 52: 477-489.
37. Yuen, J. W., L. S. Poon, A. S. Chan, F. W. Yu, R. K. Lo, and Y. H. Wong. 2010. Activation of STAT3 by specific Galpha subunits and multiple Gbetagamma dimers. Int. J. Biochem. Cell Biol. 42: 1052-1059.
38. Lappalainen, J., K. A. Lindstedt, and P. T. Kovanen. 2007. A protocol for generating high numbers of mature and functional human mast cells from peripheral blood. Clin. Exp. Allergy 37: 1404-1414. (Pubitemid 47372289)
39. Phillips, R. J., M. Lutz, and B. Premack. 2005. Differential signaling mechanisms regulate expression of CC chemokine receptor-2 during monocyte maturation. J. Inflamm. (Lond.) 2: 14.
40. McGuckin, C. P., W. M. Liu, E. C. Gordon-Smith, and M. R. Uhr. 1996. A novel approach to investigating the erythroid lineage, using both receptor analysis and haemoglobin detection. Br. J. Haematol. 95: 457-460.
41. Wen, Z., Z. Zhong, and J. E. Darnell, Jr. 1995. Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell 82: 241-250.
42. Menten, P., A. Wuyts, and J. Van Damme. 2002. Macrophage inflammatory protein-1. Cytokine Growth Factor Rev. 13: 455-481. (Pubitemid 35303816)
43. Welgus, H. G., N. L. Connolly, and R. M. Senior. 1986. 12-o-Tetradecanoylphorbol-13-acetate-differentiated U937 cells express a macrophage-like profile of neutral proteinases. High levels of secreted collagenase and collagenase inhibitor accompany low levels of intracellular elastase and cathepsin G. J. Clin. Invest. 77: 1675-1681. (Pubitemid 16047114)
44. Schust, J., B. Sperl, A. Hollis, T. U. Mayer, and T. Berg. 2006. Stattic: a small-molecule inhibitor of STAT3 activation and dimerization. Chem. Biol. 13: 1235-1242. (Pubitemid 44750735)
45. Toda, M., M. Dawson, T. Nakamura, P. M. Munro, R. M. Richardson, M. Bailly, and S. J. Ono. 2004. Impact of engagement of FcepsilonRI and CC chemokine receptor 1 on mast cell activation and motility. J. Biol. Chem. 279: 48443-48448. (Pubitemid 39541002)
46. Biswas, S. K., and A. Sodhi. 2002. Tyrosine phosphorylation-mediated signal transduction in MCP-1-induced macrophage activation: role for receptor dimerization, focal adhesion protein complex and JAK/STAT pathway. Int. Immunopharmacol. 2: 1095-1107.
47. Mellado, M., J. M. Rodríguez-Frade, A. Aragay, G. del Real, A. M. Martín, A. J. Vila-Coro, A. Serrano, F. Mayor, Jr., and C. Martínez-A. 1998. The chemokine monocyte chemotactic protein 1 triggers Janus kinase 2 activation and tyrosine phosphorylation of the CCR2B receptor. J. Immunol. 161: 805-813. (Pubitemid 28323544)
48. Vila-Coro, A. J., J. M. Rodríguez-Frade, A. Martín De Ana, M. C. Moreno-Ortíz, C. Martínez-A, and M. Mellado. 1999. The chemokine SDF-1α triggers CXCR4 receptor dimerization and activates the JAK/STAT pathway. FASEB J. 13: 1699-1710. (Pubitemid 29473332)
49. Thelen, M. 2001. Dancing to the tune of chemokines. Nat. Immunol. 2: 129-134. (Pubitemid 33707930)
50. Martinelli, R., I. Sabroe, G. LaRosa, T. J. Williams, and J. E. Pease. 2001. The CC chemokine eotaxin (CCL11) is a partial agonist of CC chemokine receptor 2b. J. Biol. Chem. 276: 42957-42964.
51. Liu, A. M., R. K. Lo, M. M. Lee, Y. Wang, W. W. Yeung, M. K. Ho, Y. Su, R. D. Ye, and Y. H. Wong. 2010. Galpha16 activates Ras by forming a complex with tetratricopeptide repeat 1 (TPR1) and Son of Sevenless (SOS). Cell. Signal. 22: 1448-1458.
52. Gerlo, S., G. Haegeman, and W. Vanden Berghe. 2008. Transcriptional regulation of autocrine IL-6 expression in multiple myeloma cells. Cell. Signal. 20: 1489-1496.
53. Wu, E. H., R. K. Lo, and Y. H. Wong. 2003. Regulation of STAT3 activity by G16-coupled receptors. Biochem. Biophys. Res. Commun. 303: 920-925. (Pubitemid 36384943)
54. Samavati, L., R. Rastogi, W. Du, M. Hüttemann, A. Fite, and L. Franchi. 2009. STAT3 tyrosine phosphorylation is critical for interleukin 1 beta and interleukin-6 production in response to lipopolysaccharide and live bacteria. Mol. Immunol. 46: 1867-1877.
55. Marrero, M. B., B. Schieffer, W. G. Paxton, L. Heerdt, B. C. Berk, P. Delafontaine, and K. E. Bernstein. 1995. Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor. Nature 375: 247-250.
56. Kodama, H., K. Fukuda, J. Pan, S. Makino, M. Sano, T. Takahashi, S. Hori, and S. Ogawa. 1998. Biphasic activation of the JAK/STAT pathway by angiotensin II in rat cardiomyocytes. Circ. Res. 82: 244-250. (Pubitemid 28080107)
57. Sano, M., K. Fukuda, H. Kodama, T. Takahashi, T. Kato, D. Hakuno, T. Sato, T. Manabe, S. Tahara, and S. Ogawa. 2000. Autocrine/Paracrine secretion of IL-6 family cytokines causes angiotensin II-induced delayed STAT3 activation. Biochem. Biophys. Res. Commun. 269: 798-802. (Pubitemid 30440380)
58. Oka, M., M. Sakaguchi, T. Okada, H. Nagai, M. Ozaki, T. Yoshioka, H. Inoue, N. Mukaida, U. Kikkawa, and C. Nishigori. 2010. Signal transducer and activator of transcription 3 upregulates interleukin-8 expression at the level of transcription in human melanoma cells. Exp. Dermatol. 19: e50-e55.
59. Wang, L., J. Luo, Y. Fu, and S. He. 2006. Induction of interleukin-8 secretion and activation of ERK1/2, p38 MAPK signaling pathways by thrombin in dermal fibroblasts. Int. J. Biochem. Cell Biol. 38: 1571-1583. (Pubitemid 43729306)
60. Moreau, M., I. Brocheriou, L. Petit, E. Ninio, M. J. Chapman, and M. Rouis. 1999. Interleukin-8 mediates downregulation of tissue inhibitor of metalloproteinase-1 expression in cholesterol-loaded human macrophages: relevance to stability of atherosclerotic plaque. Circulation 99: 420-426. (Pubitemid 29051269)
61. Burke, S. M., T. B. Issekutz, K. Mohan, P. W. Lee, M. Shmulevitz, and J. S. Marshall. 2008. Human mast cell activation with virus-associated stimuli leads to the selective chemotaxis of natural killer cells by a CXCL8-dependent mechanism. Blood 111: 5467-5476.
62. Lee, Y. S., I. Choi, Y. Ning, N. Y. Kim, V. Khatchadourian, D. Yang, H. K. Chung, D. Choi, M. J. LaBonte, R. D. Ladner, et al. 2012. Interleukin-8 and its receptor CXCR2 in the tumour microenvironment promote colon cancer growth, progression and metastasis. Br. J. Cancer 106: 1833-1841.
63. Inamura, H., M. Kurosawa, A. Okano, H. Kayaba, and M. Majima. 2002. Expression of the interleukin-8 receptors CXCR1 and CXCR2 on cord-blood-derived cultured human mast cells. Int. Arch. Allergy Immunol. 128: 142-150. (Pubitemid 34639023)
64. Juremalm, M., N. Olsson, and G. Nilsson. 2002. Selective CCL5/RANTES-induced mast cell migration through interactions with chemokine receptors CCR1 and CCR4. Biochem. Biophys. Res. Commun. 297: 480-485.
65. Burger, M., T. Hartmann, J. A. Burger, and I. Schraufstatter. 2005. KSHV-GPCR and CXCR2 transforming capacity and angiogenic responses are mediated through a JAK2-STAT3-dependent pathway. Oncogene 24: 2067-2075. (Pubitemid 40516200)
66. Shen, Y., K. Schlessinger, X. Zhu, E. Meffre, F. Quimby, D. E. Levy, and J. E. Darnell, Jr. 2004. Essential role of STAT3 in postnatal survival and growth revealed by mice lacking STAT3 serine 727 phosphorylation. Mol. Cell. Biol. 24: 407-419. (Pubitemid 38010065)
67. Wegrzyn, J., R. Potla, Y. J. Chwae, N. B. Sepuri, Q. Zhang, T. Koeck, M. Derecka, K. Szczepanek, M. Szelag, A. Gornicka, et al. 2009. Function of mitochondrial Stat3 in cellular respiration. Science 323: 793-797.